North America Stem Cell Market Forecast 2022-2030

North America Stem Cell Market Forecast 2022-2030KEY FINDINGS

The North America stem cell market is predicted to garner a CAGR of 9.01% during the forecasted years 2022 to 2030. Some of the leading aspects propelling the regional market’s growth include public awareness regarding the therapeutic potential of stem cell products, increasing public-private funding and investments in stem cell-based research, as well as technological advancements in stem cell manufacturing and preservation.

MARKET INSIGHTS

The North America stem cell market growth evaluation entails the study of Canada and the United States. As per the Canadian Institutes of Health Research, over 300,000 Canadians were estimated to have type 1 diabetes (T1D) in the year 2020. T1D is characterized as an autoimmune condition with no known origins or treatments that impacts the pancreatic beta cells responsible for the creation of insulin. However, owing to a ground-breaking new stem cell-based therapy developed by Canadian researchers, it is possible that individuals with type 1 diabetes may no longer need insulin injections.

In this regard, a team of researchers from the Vancouver Coastal Health (VCH), as well as the University of British Columbia, conducted a pioneering study demonstrating how a small implant injected with stem cells can potentially assist the body in producing insulin on its own. Moreover, given the funding of $1 million from the country’s Stem Cell Network, one of the first genetically engineered cell replacement treatments for type 1 diabetes is set to be tested in a clinical trial in 2022. Therefore, these factors are anticipated to facilitate the stem cell market growth in North America during the forecast period.

COMPETITIVE INSIGHTS

Key firms operating in the market are AllCells LLC, GE Healthcare, etc.

Our report offerings include:

• Explore key findings of the overall market

• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

• Market Segmentation caters to a thorough assessment of key segments with their market estimations

• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Demand For Stem Cells In Regenerative Medicine
3.1.2. Growing R&D Investments In Stem Cell Therapies & Research
3.1.3. Rising Awareness About Umbilical Cord Stem Cells
3.1.4. Reduced Risk Of Tissue Rejection In Transplants
3.2. Key Restraints
3.2.1. Absence Of A Well-defined Regulatory Framework For Stem Cell Therapy
3.2.2. High Costs Associated With Stem Cell Procedures
3.2.3. Ethical Issues And Social Complexities
3.2.4. Less Responsiveness In Developed Economies
4. Key Analytics
4.1. Impact Of Covid-19 On Stem Cell Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Price
4.7.2. Efficacy
4.7.3. Application And Effectiveness
4.7.4. Accuracy
4.8. Regulatory Framework
5. Market By Therapeutic Application
5.1. Orthopedic Treatments
5.2. Injuries & Wounds
5.3. Oncology Disorders
5.4. Cardiovascular Disorders
5.5. Neurological Disorders
5.6. Diabetes
5.7. Other Therapeutic Applications
6. Market By Product
6.1. Adult Stem Cell
6.1.1. Hematopoietic Stem Cell
6.1.2. Neural Stem Cell
6.1.3. Umbilical Cord Stem Cell
6.1.4. Mesenchymal Stem Cell
6.1.5. Dental Stem Cell
6.2. Human Embryonic Stem Cell
6.3. Pluripotent
6.4. Mouse/Rat Neural
7. Market By Technology
7.1. Cell Acquisition
7.1.1. Bone Marrow Harvest
7.1.2. Umbilical Cord
7.1.3. Apheresis
7.2. Cell Production
7.2.1. Therapeutic Cloning
7.2.2. In Vitro Fertilization (Ivf)
7.2.3. Cell Culture
7.2.4. Isolation
7.3. Cryopreservation
7.4. Expansion & Sub-culture
8. Market By Application
8.1. Regenerative Medicine
8.2. Drug Discovery And Development
9. Market By Treatment Type
9.1. Allogeneic Stem Cell Therapy
9.2. Autologic Stem Cell Therapy
9.3. Syngeneic Stem Cell Therapy
10. Geographical Analysis
10.1. North America
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. United States
10.1.5.2. Canada
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Acquisitions
11.1.2. Partnerships
11.2. Company Profiles
11.2.1. Allcells Llc
11.2.2. Becton, Dickinson And Company (Bd)
11.2.3. Corning Inc
11.2.4. Ge Healthcare
11.2.5. International Stem Cell Corporation
11.2.6. Lorem Cytori Inc
11.2.7. Merck Kgaa (Sigma Aldrich)
11.2.8. Miltenyi Biotec
11.2.9. Pluri Inc
11.2.10. Qiagen
11.2.11. Smith+Nephew Plc
11.2.12. Stemcell Technologies Inc
11.2.13. Stryker Corporation
11.2.14. Takara Holdings Inc
11.2.15. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings